"Protein Interaction Domains and Motifs/drug effects"[MeSH] - Search Results

Year	Number of Results
1996	5
1997	4
1998	6
1999	8
2000	9
2001	14
2002	11
2003	5
2004	4
2005	6
2006	5
2007	10
2008	14
2009	18
2010	27
2011	25
2012	26
2013	30
2014	25
2015	22
2016	22
2017	39
2018	46
2019	55
2020	46
2021	36
2022	3
2024	0

1

Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics.

Yang A, Mottillo EP. Yang A, et al. Biochem J. 2020 Mar 13;477(5):985-1008. doi: 10.1042/BCJ20190468. Biochem J. 2020. PMID: 32168372 Free PMC article. Review.

2

Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer.

Shi W, Zhang G, Ma Z, Li L, Liu M, Qin L, Yu Z, Zhao L, Liu Y, Zhang X, Qin J, Ye H, Jiang X, Zhou H, Sun H, Jiao Z. Shi W, et al. Nat Commun. 2021 May 14;12(1):2812. doi: 10.1038/s41467-021-23053-8. Nat Commun. 2021. PMID: 33990570 Free PMC article.

3

Macrocycles as protein-protein interaction inhibitors.

Dougherty PG, Qian Z, Pei D. Dougherty PG, et al. Biochem J. 2017 Mar 15;474(7):1109-1125. doi: 10.1042/BCJ20160619. Biochem J. 2017. PMID: 28298556 Free PMC article. Review.

4

Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer's Disease.

Ganeshpurkar A, Swetha R, Kumar D, Gangaram GP, Singh R, Gutti G, Jana S, Kumar D, Kumar A, Singh SK. Ganeshpurkar A, et al. Curr Top Med Chem. 2019;19(7):501-533. doi: 10.2174/1568026619666190304153353. Curr Top Med Chem. 2019. PMID: 30836921 Review.

5

Bicyclic Peptides as Next-Generation Therapeutics.

Rhodes CA, Pei D. Rhodes CA, et al. Chemistry. 2017 Sep 18;23(52):12690-12703. doi: 10.1002/chem.201702117. Epub 2017 Jul 27. Chemistry. 2017. PMID: 28590540 Free PMC article. Review.

6

Motif mediated protein-protein interactions as drug targets.

Corbi-Verge C, Kim PM. Corbi-Verge C, et al. Cell Commun Signal. 2016 Mar 2;14:8. doi: 10.1186/s12964-016-0131-4. Cell Commun Signal. 2016. PMID: 26936767 Free PMC article. Review.

7

Protein-protein interactions as drug targets.

Skwarczynska M, Ottmann C. Skwarczynska M, et al. Future Med Chem. 2015;7(16):2195-219. doi: 10.4155/fmc.15.138. Epub 2015 Oct 29. Future Med Chem. 2015. PMID: 26510391 Review.

8

Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).

Nayak SK. Nayak SK. Mini Rev Med Chem. 2021;21(6):689-703. doi: 10.2174/1389557520666201117111259. Mini Rev Med Chem. 2021. PMID: 33208074 Review.

9

Targeting protein-protein interaction by small molecules.

Jin L, Wang W, Fang G. Jin L, et al. Annu Rev Pharmacol Toxicol. 2014;54:435-56. doi: 10.1146/annurev-pharmtox-011613-140028. Epub 2013 Oct 21. Annu Rev Pharmacol Toxicol. 2014. PMID: 24160698 Review.

10

Phosphotyrosine isosteres: past, present and future.

Cerulli RA, Kritzer JA. Cerulli RA, et al. Org Biomol Chem. 2020 Jan 28;18(4):583-605. doi: 10.1039/c9ob01998g. Epub 2019 Nov 28. Org Biomol Chem. 2020. PMID: 31777907 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

461 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

461 results

Results by year